{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T23:06:06Z","timestamp":1787785566711,"version":"build-2784847793"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T00:00:00Z","timestamp":1693612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T00:00:00Z","timestamp":1693612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC -111-2634-F-A49-014"],"award-info":[{"award-number":["NSTC -111-2634-F-A49-014"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC-111-2218-E-039-001"],"award-info":[{"award-number":["NSTC-111-2218-E-039-001"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC-111-2314-B-075A-003-MY3"],"award-info":[{"award-number":["NSTC-111-2314-B-075A-003-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010101","name":"Taichung Veterans General Hospital","doi-asserted-by":"publisher","award":["TCVGH-1123801A"],"award-info":[{"award-number":["TCVGH-1123801A"]}],"id":[{"id":"10.13039\/501100010101","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010101","name":"Taichung Veterans General Hospital","doi-asserted-by":"publisher","award":["TCVGH-1127301C"],"award-info":[{"award-number":["TCVGH-1127301C"]}],"id":[{"id":"10.13039\/501100010101","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010101","name":"Taichung Veterans General Hospital","doi-asserted-by":"publisher","award":["TCVGH-1127302D"],"award-info":[{"award-number":["TCVGH-1127302D"]}],"id":[{"id":"10.13039\/501100010101","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010101","name":"Taichung Veterans General Hospital","doi-asserted-by":"publisher","award":["TCVGH-YM1120110"],"award-info":[{"award-number":["TCVGH-YM1120110"]}],"id":[{"id":"10.13039\/501100010101","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1007\/s10067-023-06735-0","type":"journal-article","created":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T11:01:40Z","timestamp":1693652500000},"page":"117-128","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Potential alleviation of bone mineral density loss with Janus kinase inhibitors in rheumatoid arthritis"],"prefix":"10.1007","volume":"43","author":[{"given":"Yun-Wen","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsin-Hua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Nan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Peng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Hsing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7593-3065","authenticated-orcid":false,"given":"Yi-Ming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,2]]},"reference":[{"key":"6735_CR1","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1080\/14656566.2020.1787381","volume":"21","author":"HG Raterman","year":"2020","unstructured":"Raterman HG, Bultink IE, Lems WF (2020) Osteoporosis in patients with rheumatoid arthritis: an update in epidemiology, pathogenesis, and fracture prevention. Expert Opin Pharmacother 21:1725\u20131737. https:\/\/doi.org\/10.1080\/14656566.2020.1787381","journal-title":"Expert Opin Pharmacother"},{"key":"6735_CR2","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s11657-014-0182-3","volume":"9","author":"SW Wade","year":"2014","unstructured":"Wade SW, Strader C, Fitzpatrick LA, Anthony MS, O\u2019Malley CD (2014) Estimating prevalence of osteoporosis: examples from industrialized countries. Arch Osteoporos 9:182. https:\/\/doi.org\/10.1007\/s11657-014-0182-3","journal-title":"Arch Osteoporos"},{"key":"6735_CR3","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/1529-0131(200003)43:3%3C522::aid-anr7%3E3.0.co;2-y","volume":"43","author":"G Haugeberg","year":"2000","unstructured":"Haugeberg G, Uhlig T, Falch JA, Halse JI, Kvien TK (2000) Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County Rheumatoid Arthritis register. Arthritis Rheum 43:522\u2013530. https:\/\/doi.org\/10.1002\/1529-0131(200003)43:3%3C522::aid-anr7%3E3.0.co;2-y","journal-title":"Arthritis Rheum"},{"key":"6735_CR4","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1093\/rheumatology\/keu162","volume":"53","author":"B Hauser","year":"2014","unstructured":"Hauser B, Riches PL, Wilson JF, Horne AE, Ralston SH (2014) Prevalence and clinical prediction of osteoporosis in a contemporary cohort of patients with rheumatoid arthritis. Rheumatology (Oxford) 53:1759\u20131766. https:\/\/doi.org\/10.1093\/rheumatology\/keu162","journal-title":"Rheumatology (Oxford)"},{"key":"6735_CR5","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1007\/s00198-018-4473-1","volume":"29","author":"S Jin","year":"2018","unstructured":"Jin S, Hsieh E, Peng L et al (2018) Incidence of fractures among patients with rheumatoid arthritis: a systematic review and meta-analysis. Osteoporos Int 29:1263\u20131275. https:\/\/doi.org\/10.1007\/s00198-018-4473-1","journal-title":"Osteoporos Int"},{"key":"6735_CR6","doi-asserted-by":"publisher","first-page":"R205","DOI":"10.1186\/ar4398","volume":"15","author":"S Revu","year":"2013","unstructured":"Revu S, Nereg\u00e5rd P, afKlint E, Korotkova M, Catrina AI (2013) Synovial membrane immunohistology in early-untreated rheumatoid arthritis reveals high expression of catabolic bone markers that is modulated by methotrexate. Arthritis Res Ther 15:R205. https:\/\/doi.org\/10.1186\/ar4398","journal-title":"Arthritis Res Ther"},{"key":"6735_CR7","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/2Fs13075-015-0760-9","volume":"17","author":"AH Hensvold","year":"2015","unstructured":"Hensvold AH, Joshua V, Li W et al (2015) Serum RANKL levels associate with anti- citrullinated protein antibodies in early untreated rheumatoid arthritis and are modulated following methotrexate. Arthritis Res Ther 17:239. https:\/\/doi.org\/10.1186\/2Fs13075-015-0760-9","journal-title":"Arthritis Res Ther"},{"key":"6735_CR8","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s10067-019-04771-3","volume":"39","author":"K Guly\u00e1s","year":"2020","unstructured":"Guly\u00e1s K, Horv\u00e1th \u00c1, V\u00e9gh E et al (2020) Effects of 1-year anti-TNF-\u03b1 therapies on bone mineral density and bone biomarkers in rheumatoid arthritis and ankylosing spondylitis. Clin Rheumatol 39:167\u2013175. https:\/\/doi.org\/10.1007\/s10067-019-04771-3","journal-title":"Clin Rheumatol"},{"key":"6735_CR9","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1007\/s00198-021-05871-0","volume":"32","author":"A Hamar","year":"2021","unstructured":"Hamar A, Szekanecz Z, Pusztai A et al (2021) Effects of one-year tofacitinib therapy on bone metabolism in rheumatoid arthritis. Osteoporos Int 32:1621\u20131629. https:\/\/doi.org\/10.1007\/s00198-021-05871-0","journal-title":"Osteoporos Int"},{"key":"6735_CR10","doi-asserted-by":"publisher","first-page":"e0188454","DOI":"10.1371\/journal.pone.0188454","volume":"12","author":"YM Chen","year":"2017","unstructured":"Chen YM, Chen HH, Huang WN et al (2017) Tocilizumab potentially prevents bone loss in patients with anticitrullinated protein antibody-positive rheumatoid arthritis. Plos One 12:e0188454. https:\/\/doi.org\/10.1371\/journal.pone.0188454","journal-title":"Plos One"},{"key":"6735_CR11","doi-asserted-by":"publisher","first-page":"e0201527","DOI":"10.1371\/journal.pone.0201527","volume":"13","author":"G Wheater","year":"2018","unstructured":"Wheater G, Elshahaly M, Naraghi K, Tuck SP, Datta HK, van Laar JM (2018) Changes in bone density and bone turnover in patients with rheumatoid arthritis treated with rituximab, results from an exploratory, prospective study. Plos One 13:e0201527. https:\/\/doi.org\/10.1371\/journal.pone.0201527","journal-title":"Plos One"},{"key":"6735_CR12","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1007\/s00296-017-3922-z","volume":"38","author":"M Tada","year":"2018","unstructured":"Tada M, Inui K, Sugioka Y, Mamoto K, Okano T, Koike T (2018) Abatacept might increase bone mineral density at femoral neck for patients with rheumatoid arthritis in clinical practice: AIRTIGHT study. Rheumatol Int 38:777\u2013784. https:\/\/doi.org\/10.1007\/s00296-017-3922-z","journal-title":"Rheumatol Int"},{"key":"6735_CR13","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1002\/art.41623","volume":"73","author":"JAMP Amkreutz","year":"2021","unstructured":"Amkreutz JAMP, de Moel EC, Theander L et al (2021) Association between bone mineral density and autoantibodies in patients with rheumatoid arthritis. Arthritis Rheumatol 73:921\u2013930. https:\/\/doi.org\/10.1002\/art.41623","journal-title":"Arthritis Rheumatol"},{"key":"6735_CR14","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1093\/rheumatology\/kes320","volume":"52","author":"CL Krieckaert","year":"2013","unstructured":"Krieckaert CL, Nurmohamed MT, Wolbink G, Lems WF (2013) Changes in bone mineral density during long-term treatment with adalimumab in patients with rheumatoid arthritis: a cohort study. Rheumatology (Oxford) 52:547\u2013553. https:\/\/doi.org\/10.1093\/rheumatology\/kes320","journal-title":"Rheumatology (Oxford)"},{"key":"6735_CR15","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1136\/annrheumdis-2019-215764","volume":"78","author":"RM Fleischmann","year":"2019","unstructured":"Fleischmann RM, Genovese MC, Enejosa JV et al (2019) Safety and effectiveness of upadacitinib or adalimumab plus methotrexate in patients with rheumatoid arthritis over 48 weeks with switch to alternate therapy in patients with insufficient response. Ann Rheum Dis 78:1454\u20131462. https:\/\/doi.org\/10.1136\/annrheumdis-2019-215764","journal-title":"Ann Rheum Dis"},{"key":"6735_CR16","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1002\/art.1780350502","volume":"35","author":"MC Hochberg","year":"1992","unstructured":"Hochberg MC, Chang RW, Dwosh I, Lindsey S, Pincus T, Wolfe F (1992) The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum 35:498\u2013502. https:\/\/doi.org\/10.1002\/art.1780350502","journal-title":"Arthritis Rheum"},{"key":"6735_CR17","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ et al (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62:2569\u20132581. https:\/\/doi.org\/10.1002\/art.27584","journal-title":"Arthritis Rheum"},{"key":"6735_CR18","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1093\/rheumatology\/keh297","volume":"43","author":"J Fransen","year":"2004","unstructured":"Fransen J, Creemers MC, Van Riel PL (2004) Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria. Rheumatology (Oxford) 43:1252\u20131255. https:\/\/doi.org\/10.1093\/rheumatology\/keh297","journal-title":"Rheumatology (Oxford)"},{"key":"6735_CR19","unstructured":"World Health Organization (2007) Assessment of osteoporosis at the primary health care level. WHO, Geneva (www.who.int\/chp\/topics\/rheumatic\/en\/index.html)"},{"key":"6735_CR20","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/s41584-022-00764-w","volume":"18","author":"B So\u00f3s","year":"2022","unstructured":"So\u00f3s B, Szentp\u00e9tery \u00c1, Raterman HG, Lems WF, Bhattoa HP, Szekanecz Z (2022) Effects of targeted therapies on bone in rheumatic and musculoskeletal diseases. Nat Rev Rheumatol 18:249\u2013257. https:\/\/doi.org\/10.1038\/s41584-022-00764-w","journal-title":"Nat Rev Rheumatol"},{"key":"6735_CR21","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s002239900585","volume":"64","author":"LD Carbone","year":"1999","unstructured":"Carbone LD, Kaeley G, McKown KM, Cremer M, Palmieri G, Kaplan S (1999) Effects of long-term administration of methotrexate on bone mineral density in rheumatoid arthritis. Calcif Tissue Int 64:100\u2013101. https:\/\/doi.org\/10.1007\/s002239900585","journal-title":"Calcif Tissue Int"},{"key":"6735_CR22","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s13075-020-02379-6","volume":"23","author":"P Emery","year":"2021","unstructured":"Emery P, Durez P, Hueber AJ et al (2021) Baricitinib inhibits structural joint damage progression in patients with rheumatoid arthritis-a comprehensive review. Arthritis Res Ther 23:3. https:\/\/doi.org\/10.1186\/s13075-020-02379-6","journal-title":"Arthritis Res Ther"},{"key":"6735_CR23","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1007\/2Fs10067-018-4221-0","volume":"37","author":"D van der Heijde","year":"2018","unstructured":"van der Heijde D, Durez P, Schett G et al (2018) Structural damage progression in patients with early rheumatoid arthritis treated with methotrexate, baricitinib, or baricitinib plus methotrexate based on clinical response in the phase 3 RA-BEGIN study. Clin Rheumatol 37:2381\u201390. https:\/\/doi.org\/10.1007\/2Fs10067-018-4221-0","journal-title":"Clin Rheumatol"},{"key":"6735_CR24","doi-asserted-by":"publisher","first-page":"1394","DOI":"10.3390\/jcm8091394","volume":"8","author":"B Fautrel","year":"2019","unstructured":"Fautrel B, Kirkham B, Pope JE et al (2019) Effect of baricitinib and adalimumab in reducing pain and improving function in patients with rheumatoid arthritis in low disease activity: exploratory analyses from RA-BEAM. J Clin Med 8:1394. https:\/\/doi.org\/10.3390\/jcm8091394","journal-title":"J Clin Med"},{"key":"6735_CR25","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1136\/annrheumdis-2016-210094","volume":"76","author":"M Dougados","year":"2017","unstructured":"Dougados M, van der Heijde D, Chen YC et al (2017) Baricitinib in patients with inadequate response or intolerance to conventional synthetic DMARDs: results from the RA-BUILD study. Ann Rheum Dis 76:88\u201395. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210094","journal-title":"Ann Rheum Dis"},{"key":"6735_CR26","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3899\/jrheum.210346","volume":"49","author":"D van der Heijde","year":"2022","unstructured":"van der Heijde D, Kartman CE, Xie L et al (2022) Radiographic progression of structural joint damage over 5 years of baricitinib treatment in patients with rheumatoid arthritis: results From RA-BEYOND. J Rheumatol 49:133\u2013141. https:\/\/doi.org\/10.3899\/jrheum.210346","journal-title":"J Rheumatol"},{"key":"6735_CR27","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1186\/s13075-020-02340-7","volume":"22","author":"CS Thudium","year":"2020","unstructured":"Thudium CS, Bay-Jensen AC, Cahya S et al (2020) The Janus kinase 1\/2 inhibitor baricitinib reduces biomarkers of joint destruction in moderate to severe rheumatoid arthritis. Arthritis Res Ther 22:235. https:\/\/doi.org\/10.1186\/s13075-020-02340-7","journal-title":"Arthritis Res Ther"},{"key":"6735_CR28","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1093\/rheumatology\/key416","volume":"58","author":"N Ishiguro","year":"2019","unstructured":"Ishiguro N, Tanaka Y, Yamanaka H et al (2019) Efficacy of denosumab with regard to bone destruction in prognostic subgroups of Japanese rheumatoid arthritis patients from the phase II DRIVE study. Rheumatology (Oxford) 58:997\u20131005. https:\/\/doi.org\/10.1093\/rheumatology\/key416","journal-title":"Rheumatology (Oxford)"},{"key":"6735_CR29","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1007\/s00296-015-3271-8","volume":"35","author":"W Katchamart","year":"2015","unstructured":"Katchamart W, Koolvisoot A, Aromdee E, Chiowchanwesawakit P, Muengchan C (2015) Associations of rheumatoid factor and anti-citrullinated peptide antibody with disease progression and treatment outcomes in patients with rheumatoid arthritis. Rheumatol Int 35:1693\u20131699. https:\/\/doi.org\/10.1007\/s00296-015-3271-8","journal-title":"Rheumatol Int"},{"key":"6735_CR30","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1172\/jci60975","volume":"122","author":"U Harre","year":"2012","unstructured":"Harre U, Georgess D, Bang H et al (2012) Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. J Clin Invest 122:1791\u20131802. https:\/\/doi.org\/10.1172\/jci60975","journal-title":"J Clin Invest"},{"key":"6735_CR31","doi-asserted-by":"publisher","first-page":"6651","DOI":"10.1038\/ncomms7651","volume":"6","author":"U Harre","year":"2015","unstructured":"Harre U, Lang SC, Pfeifle R et al (2015) Glycosylation of immunoglobulin G determines osteoclast differentiation and bone loss. Nat Commun 6:6651. https:\/\/doi.org\/10.1038\/ncomms7651","journal-title":"Nat Commun"},{"key":"6735_CR32","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1136\/annrheumdis-2012-201517","volume":"72","author":"D Aletaha","year":"2013","unstructured":"Aletaha D, Alasti F, Smolen JS (2013) Rheumatoid factor determines structural progression of rheumatoid arthritis dependent and independent of disease activity. Ann Rheum Dis 72:875\u2013880. https:\/\/doi.org\/10.1136\/annrheumdis-2012-201517","journal-title":"Ann Rheum Dis"},{"key":"6735_CR33","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1136\/ard.2010.142091","volume":"70","author":"L Laurent","year":"2011","unstructured":"Laurent L, Clavel C, Lemaire O et al (2011) Fc\u03b3 receptor profile of monocytes and macrophages from rheumatoid arthritis patients and their response to immune complexes formed with autoantibodies to citrullinated proteins. Ann Rheum Dis 70:1052\u20131059. https:\/\/doi.org\/10.1136\/ard.2010.142091","journal-title":"Ann Rheum Dis"},{"key":"6735_CR34","doi-asserted-by":"publisher","first-page":"2151","DOI":"10.1136\/annrheumdis-2014-205428","volume":"74","author":"C Hecht","year":"2015","unstructured":"Hecht C, Englbrecht M, Rech J et al (2015) Additive effect of anti-citrullinated protein antibodies and rheumatoid factor on bone erosions in patients with RA. Ann Rheum Dis 74:2151\u20132156. https:\/\/doi.org\/10.1136\/annrheumdis-2014-205428","journal-title":"Ann Rheum Dis"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06735-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-023-06735-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-023-06735-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,8]],"date-time":"2024-01-08T05:09:57Z","timestamp":1704690597000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-023-06735-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,2]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["6735"],"URL":"https:\/\/doi.org\/10.1007\/s10067-023-06735-0","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,2]]},"assertion":[{"value":"23 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of the Taichung Veterans General Hospital (CE17111A). The participants\u2019 data were anonymized, and, therefore, the requirement of informed consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare that they have no conflict of interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interests"}}]}}